Tumor cell-selective apoptosis induction through targeting of K(V)10.1 via bifunctional TRAIL antibody.

Mol Cancer · 2011 · PMC3179451 · PMID 21899742

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Combinational treatment with scFv62-TRAIL and etoposide or 5-fluorouracil significantly increased the apoptosis induction by scFv62-TRAIL, whereas the increase in apoptosis produced by combination with actinomycin D, doxorubicin or roscovitine did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.